← Eichor
Study identifier: NCT06038162 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients

Condition: Venoarterial Extracorporeal Membrane Oxygenation · Renal Replacement Therapy · Acute Kidney Injury  ·  Sponsor: Hospices Civils de Lyon

PhaseNA
Planned participants158
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Extracorporeal membrane oxygenation (ECMO) is an extra-corporeal assistance used in case of respiratory or circulatory failure. In case of circulatory failure, ECMO is in the veno-arterial configuration (VA-ECMO). VA-ECMO patients are at high risk of developing acute kidney injury (AKI) and renal replacement therapy (RRT) may be needed in 50% of ECMO patients. Although the administration of RRT in ECMO patients has major implications, no specific recommendations are currently available. The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) international conference identified the evaluation of RRT in these ECMO patients as a research priority. In 2023, the two main configurations used to administer RRT in ECMO patients are an independent delivery on a separate vascular access (parallel connection) or an integration of the RRT machine directly into the ECMO circuit (integrated connection). The integrated connection may reduce infectious and bleeding complications associated with the use of a second vascular access. However, it can expose the hemofilter and circuit to excessive positive pressures that can trigger pressure alarms in the RRT machine and expose the patient to a theoretical risk of air embolism or hemolysis. Furthermore, there is currently no robust data comparing the hemofilter lifespan with the parallel or with the integrated connection, although the filter lifespan is a crucial parameter to assess the quality of the RRT delivery in the ICU. The investigator…

This description comes directly from the study's public registry record.

Talk to the study team

Frank BIDAR, MD  ·  (33) 472 116 942  ·  frank.bidar@chu-lyon.fr

Thomas RIMMELE, Professor MD  ·  (33) 472 111 327  ·  thomas.rimmele@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (12)

CHU de Bordeaux, GH Sud, Service d'anesthésie-réanimation cardiovasculaire, Hôpital cardiologiqueBordeaux, FranceRecruiting
CHU de Clermont Ferrand, Pôle de médecine péri-opératoire/Chirurgie cardiaque, Hôpital Gabriel MontpiedClermont-Ferrand, FranceRecruiting
Centre Hospitalo Universitaire de Dijon, Unité Réanimation Cardio-Vasculaire,Dijon, FranceRecruiting
CHU de Grenoble, Service de réanimation cardiovasculaire et thoracique, Pôle anesthésie réanimation, Hôpital NordGrenoble, FranceRecruiting
Centre Hospitalo Universitaire de Lille, Institut Coeur PoumonLille, FranceNot Yet Recruiting
Hospices Civils de Lyon, Service d'Anesthésie-Réanimation cardiovasculaire, Hôpital Louis PradelLyon, FranceRecruiting
CHU de Montpellier, Département d'anesthésie-réanimation, Pôle Cœur-poumons, Hôpital Arnaud de VilleneuveMontpellier, FranceRecruiting
APHP, Institut de Cardiologie, Service d'anesthésie-réanimation cardiovasculaire, Hôpital de la Pitié-SalpêtrièreParis, FranceRecruiting
APHP, Institut de cardiologie, Service de Médecine Intensive Réanimation, Hôpital Pitié-SalpêtrièreParis, FranceRecruiting
CHU de Saint Etienne, Hôpital Bellevue, Service de Réanimation polyvalente et soins intensifs post-opératoiresSaint-Etienne, FranceRecruiting
Centre Hospitalo Universitaire de Toulouse, Hôpital Rangueil - Réanimation polyvalenteToulouse, FranceNot Yet Recruiting
Centre Hospitalo Universitaire de Toulouse, Unité de Chirurgie CardiaqueToulouse, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06038162